BCM
DXCM icon

Blume Capital Management’s DexCom DXCM Stock Holding History

Blume Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22
Closed -$1.48K – 331
2024
Q3 		$1.48K Buy
+22
New +$1.81K ﹤0.01% 331

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Blume Capital Management's DXCM Position: Q4 2024 in Review

Blume Capital Management sold out of DexCom (DXCM) in Q4 2024, closing a stake of 22 shares — an estimated $1.48K sold.

Blume Capital Management first reported a position in DXCM in Q3 2024 and held it in 1 quarter. The position peaked at $1.48K in Q3 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Blume Capital Management reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Blume Capital Management sold 22 DexCom shares in Q4 2024, an estimated $1.48K.
  • Blume Capital Management first reported a position in DexCom in Q3 2024 and held it in 1 quarter.
  • Blume Capital Management's DexCom position peaked at $1.48K in Q3 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Blume Capital Management's 13F filing for Q4 2024, filed 10 Feb 2025.